Kalgutkar AS - Search Results

1

Kinetics of the interaction of nonsteroidal antiinflammatory drugs with prostaglandin endoperoxide synthase-1 studied by limited proteolysis.

Kalgutkar AS, Crews BC, Marnett LJ. Kalgutkar AS, et al. Biochemistry. 1996 Jul 16;35(28):9076-82. doi: 10.1021/bi9605752. Biochemistry. 1996. PMID: 8703911

2

Amide derivatives of meclofenamic acid as selective cyclooxygenase-2 inhibitors.

Kalgutkar AS, Rowlinson SW, Crews BC, Marnett LJ. Kalgutkar AS, et al. Bioorg Med Chem Lett. 2002 Feb 25;12(4):521-4. doi: 10.1016/s0960-894x(01)00792-2. Bioorg Med Chem Lett. 2002. PMID: 11844663

3

Rapid inactivation of prostaglandin endoperoxide synthases by N-(carboxyalkyl)maleimides.

Kalgutkar AS, Marnett LJ. Kalgutkar AS, et al. Biochemistry. 1994 Jul 26;33(29):8625-8. doi: 10.1021/bi00195a002. Biochemistry. 1994. PMID: 8038151

4

Design, synthesis, and biochemical evaluation of N-substituted maleimides as inhibitors of prostaglandin endoperoxide synthases.

Kalgutkar AS, Crews BC, Marnett LJ. Kalgutkar AS, et al. J Med Chem. 1996 Apr 12;39(8):1692-703. doi: 10.1021/jm950872p. J Med Chem. 1996. PMID: 8648609

5

Inactivation of prostaglandin endoperoxide synthase (PGHS) by N-(substituted)maleimides.

Kalgutkar AS, Crews BC, Marnett LJ. Kalgutkar AS, et al. Adv Exp Med Biol. 1997;407:79-85. doi: 10.1007/978-1-4899-1813-0_12. Adv Exp Med Biol. 1997. PMID: 9321935 No abstract available.

6

Design of selective inhibitors of cyclooxygenase-2 as nonulcerogenic anti-inflammatory agents.

Marnett LJ, Kalgutkar AS. Marnett LJ, et al. Among authors: kalgutkar as. Curr Opin Chem Biol. 1998 Aug;2(4):482-90. doi: 10.1016/s1367-5931(98)80124-5. Curr Opin Chem Biol. 1998. PMID: 9736921 Review.

7

Covalent modification of cyclooxygenase-2 (COX-2) by 2-acetoxyphenyl alkyl sulfides, a new class of selective COX-2 inactivators.

Kalgutkar AS, Kozak KR, Crews BC, Hochgesang GP Jr, Marnett LJ. Kalgutkar AS, et al. J Med Chem. 1998 Nov 19;41(24):4800-18. doi: 10.1021/jm980303s. J Med Chem. 1998. PMID: 9822550

8

Cyclooxygenase 2 inhibitors: discovery, selectivity and the future.

Marnett LJ, Kalgutkar AS. Marnett LJ, et al. Among authors: kalgutkar as. Trends Pharmacol Sci. 1999 Nov;20(11):465-9. doi: 10.1016/s0165-6147(99)01385-1. Trends Pharmacol Sci. 1999. PMID: 10542447 Review.

9

Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors.

Kalgutkar AS, Crews BC, Rowlinson SW, Marnett AB, Kozak KR, Remmel RP, Marnett LJ. Kalgutkar AS, et al. Proc Natl Acad Sci U S A. 2000 Jan 18;97(2):925-30. doi: 10.1073/pnas.97.2.925. Proc Natl Acad Sci U S A. 2000. PMID: 10639181 Free PMC article.

10

Ester and amide derivatives of the nonsteroidal antiinflammatory drug, indomethacin, as selective cyclooxygenase-2 inhibitors.

Kalgutkar AS, Marnett AB, Crews BC, Remmel RP, Marnett LJ. Kalgutkar AS, et al. J Med Chem. 2000 Jul 27;43(15):2860-70. doi: 10.1021/jm000004e. J Med Chem. 2000. PMID: 10956194

Recent studies from our laboratory have shown that derivatization of the carboxylate moiety in substrate analogue inhibitors, such as 5,8,11,14-eicosatetraynoic acid, and in nonsteroidal antiinflammatory drugs (NSAIDs), such as indomethacin and meclofenamic acid, re …

Recent studies from our laboratory have shown that derivatization of the carboxylate moiety in substrate analogue inhibitors, such as …

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

175 results

Search Page

Filters